Has Caio Teixeira Heleno received payments from drug or device companies?

Yes. Drug and device makers reported $8,873 in general payments to Caio Teixeira Heleno across 348 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Caio Teixeira Heleno did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Caio Teixeira Heleno come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Caio Teixeira Heleno

Hematology & Oncology · Pittsfield, MANPI 1578115077

Payments from drug & device makers

$8,873in general payments, 2019–2025

Across 348 payments — averaging $25.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$905
Daiichi Sankyo Inc.$809
Sanofi$661
Incyte Corporation$559
E.r. Squibb & Sons, L.L.C.$483
Pfizer$391
plus $5K from 37 others

What the payments were for

Food & beverage$8,50296%
Education$3714%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	44	$905
Daiichi Sankyo Inc.	32	$809
Sanofi	12	$661
Incyte Corporation	21	$559
E.r. Squibb & Sons, L.L.C.	32	$483
Pfizer	16	$391
Regeneron Healthcare Solutions, Inc.	10	$372
AstraZeneca(2 entities)	10	$359
Gilead(2 entities)	12	$356
Johnson & Johnson	14	$322
Adaptive Biotechnologies Corporation	6	$280
Bayer	12	$238
Pharmacyclics LLC, An Abbvie Company	8	$230
Merck	12	$227
Seagen Inc.	8	$214
Bristol Myers Squibb	7	$206
Mirati Therapeutics, Inc.	8	$203
Recordati_rare_diseases_inc.	3	$163
Beigene USA, Inc.	3	$162
AbbVie	7	$140
Amgen	6	$132
Rigel Pharmaceuticals, Inc.	6	$131
EMD Serono, Inc.	4	$114
Eisai Inc.	5	$104
ADC Therapeutics America, Inc.	6	$100
Novocure Inc.	1	$97
Boehringer Ingelheim	3	$96
Sobi, Inc	4	$96
Blueprint Medicines Corporation	4	$90
Stemline Therapeutics Inc.	4	$85
Takeda Pharmaceuticals U.S.A., Inc.	3	$82
Puma Biotechnology, Inc.	4	$70
Coherus Oncology, Inc.	3	$60
Genentech USA, Inc.	3	$57
Pharmacosmos Therapeutics Inc.	2	$45
Pharmaessentia USA Corporation	2	$40
Sumitomo Pharma America, Inc.	2	$39
Lilly USA, LLC	2	$37
Apellis Pharmaceuticals, Inc.	2	$33
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$31
Ipsen Biopharmaceuticals, Inc	1	$20
CTI Biopharma Corp.	1	$19
Agios Pharmaceuticals, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,873 in reported general payments places this provider in the 50th percentile of 374 hematology & oncology providers in Massachusetts.

See all hematology & oncology providers in Massachusetts →

Other hematology & oncology in Pittsfield

Matthew DavidsBoston$58.6M
Nadine TungBoston$32.4M
Jorge CastilloBoston$31.2M
Daniel DeangeloBoston$28.5M
Sara TolaneyBoston$20.3M
Austin KimWorcester$19.3M
Paul RichardsonBoston$17.2M
Amir FathiBoston$14.8M
Jacqueline GarciaBoston$13.6M
Jacob SandsBurlington$13.3M

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →